The detection of antibodies to blood group antigens is crucial in pre and post transfusion testing to allow for adequate blood supply of patients requiring blood transfusions. In cases when e.g. antibody mixtures, autoantibodies or alloantibodies to high prevalence blood group antigens are present, the clear identification could be problematic due to unspecific positive (false positive) or overlapping reactions in antibody screening. Recombinant blood group antigens (rBGA) by imusyn can specifically inhibit antibodies and therefore minimize the risk of incompatible blood transfusions.
Features
Simple test procedure
Direct antibody identification
Antibody detection and identification in one step
Simple and fast detection and identification of alloantibodies to high-prevalence blood group antigens
Better resolution of antibody mixtures
Neutralization of clinically insignificant antibodies to high-prevalence antigens in pretransfusion cross-matching
Faster and safer treatment of immunized patients
Easy to implement in routine serology
Long shelf life of rBGA of 18 months
Additional Images
Resources
pdf
Product Information
Related Products
Would you like to know more ?
Just fill in the details below and we will get one of our helpful team to give you a shout !
Thank you for reaching out to us
we've received your message and will get back to you shortly.